Stocks of Ideaya Biosciences Inc (NASDAQ:IDYA) traded higher last session on Wall Street, down -3.37% to $37.32.
IDYA stock price is now -3.57% away from the 50-day moving average and 0.83% away from the 200-day moving average. The market capitalization of the company currently stands at $2.82B.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
With the price target of $50, Mizuho recently initiated with Outperform rating for Ideaya Biosciences Inc (NASDAQ: IDYA). On March 08, 2024, BTIG Research recently initiated its ‘Buy’ rating on the stock quoting a target price of $55, while ‘SVB Securities’ rates the stock as ‘Outperform’
In other news, WHITE MICHAEL ANTHONY, Chief Scientific Officer sold 28,500 shares of the company’s stock on May 29 ’24. The stock was sold for $1,032,884 at an average price of $36.24. Upon completion of the transaction, the Chief Scientific Officer now directly owns 0 shares in the company, valued at $0.0. An SEC document containing details of the transaction can be found on the SEC’s website. On May 16 ’24, President and CEO Hata Yujiro S sold 34,433 shares of the business’s stock. A total of $1,439,754 was realized by selling the stock at an average price of $41.81. This leaves the insider owning 677,887 shares of the company worth $25.3 million. A total of 10.68% of the company’s stock is owned by insiders.
During the past 12 months, Ideaya Biosciences Inc has had a low of $20.90 and a high of $47.74. As of last week, the company has a debt-to-equity ratio of 0.00, a current ratio of 28.42, and a quick ratio of 28.42. The fifty day moving average price for IDYA is $38.6512 and a two-hundred day moving average price translates $37.0598 for the stock.
The latest earnings results from Ideaya Biosciences Inc (NASDAQ: IDYA) was released for 2024-03-31. The net profit margin was -831.30% and return on equity was -20.31% for IDYA.
